PB1901 IBRUTINIB, SINGLE AGENT BTK INHIBITOR, FOR RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA: A REAL-WORLD EXPERIENCE FROM RETE EMATOLOGICA PUGLIESE (REP)

Autor:	Nicola Cascavilla, Giorgio Rossi, Patrizio Mazza, Giacomo Loseto, Vincenzo Pavone, Maria Rosa Valvano, Annamaria Giordano, N. Di Renzo, Giovanni Quintana, Alessandro Maggi, Domenico Pastore, M. R. De Paolis, Giorgina Specchia, Attilio Guarini, Giuseppe Tarantini, G. De Santis, Antonino Greco, Potito Rosario Scalzulli
Rok vydání:	2019
Předmět:	biology business.industry Chronic lymphocytic leukemia Hematology medicine.disease chemistry.chemical_compound chemistry Ibrutinib Relapsed refractory biology.protein Cancer research Medicine Bruton's tyrosine kinase Single agent business
Zdroj:	HemaSphere. 3:866-867
ISSN:	2572-9241
DOI:	10.1097/01.hs9.0000566108.23806.7d
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::30be95073fdc6aa09d7142075766d7fc https://doi.org/10.1097/01.hs9.0000566108.23806.7d Zobrazit plný text záznamu Plný text